Eli Lilly cuts Zepbound prices in competitive weight loss drug market battle

Eli Lilly on Monday announced new price cuts for its popular weight loss drug Zepbound, broadening access for patients and driving greater use of the company’s digital healthcare platform, LillyDirect. Single-dose vials of Zepbound purchased through the Zepbound Self Pay Journey Program on LillyDirect will now cost $299 per month – down from $349 – for patients with a valid prescription.The 5-milligram dose will also be priced at $399 per month, down from $499. All other approved doses will cost $449 per mo ...